Neutrophil-Lymphocyte Ratio as a Prognostic Parameter in NSCLC Patients Receiving EGFR-TKIs: A Systematic Review and Meta-Analysis.
Mingbo TangXinliang GaoHe SunSuyan TianJunxue DongZhao LiuWei LiuPublished in: Journal of oncology (2021)
In conclusion, our meta-analysis revealed that lower NLR predicted a better survival (PFS and OS) in patients receiving the treatment of EGFR-TKIs.